









市场行情
/
股票
/
nasdaq-brkr
/

Bruker Corp

BRKR

44.960USD

-0.710-1.55%

收盘 12/16, 16:00（美东）报价延迟15分钟

6.81B总市值

亏损市盈率 TTM



Bruker Corp

44.960

-0.710-1.55%

概览公司财务分析

概览

公司

财务

分析

关于 Bruker Corp 公司

Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.

Bruker Corp简介



公司代码BRKR

公司名称Bruker Corp

上市日期Aug 04, 2000

CEOPrause (Burkhard A)

员工数量11396

证券类型Ordinary Share

年结日Aug 04

公司地址40 Manning Rd

城市BILLERICA

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编01821-3915

电话19786633660

网址https://www.bruker.com/

公司代码BRKR

上市日期Aug 04, 2000

CEOPrause (Burkhard A)

Bruker Corp公司高管



名称

名称/职务

职务

持股

持股变动

Dr. Frank H. Laukien, Ph.D.

Chairman of the Board, President, Chief Executive Officer

40.41M

+0.08%

Dr. Mark Robert Munch, Ph.D.

Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division

95.36K

+24.98%

Mr. Richard A. Packer

Independent Director

85.88K

+6.15%

Mr. Gerald N. Herman

Chief Financial Officer, Executive Vice President

70.13K

+41.65%

Dr. Falko Busse, Ph.D.

President - Bruker BioSpin Group

35.59K

+35.29%

Mr. John A. Ornell, CPA

Independent Director

31.91K

+13.38%

Dr. Hermann Fritz Requardt, Ph.D.

Independent Director

23.15K

-3.83%

Ms. Adelene Q. Perkins

Independent Director

21.33K

-4.14%

Dr. Cynthia M. Friend, Ph.D.

Independent Director

14.72K

+5.48%

Ms. Bonnie H. Anderson

Independent Director

10.03K

-8.41%

名称

名称/职务

职务

持股

持股变动

Dr. Frank H. Laukien, Ph.D.

Chairman of the Board, President, Chief Executive Officer

40.41M

+0.08%

Dr. Mark Robert Munch, Ph.D.

Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division

95.36K

+24.98%

Mr. Richard A. Packer

Independent Director

85.88K

+6.15%

Mr. Gerald N. Herman

Chief Financial Officer, Executive Vice President

70.13K

+41.65%

Dr. Falko Busse, Ph.D.

President - Bruker BioSpin Group

35.59K

+35.29%

Mr. John A. Ornell, CPA

Independent Director

31.91K

+13.38%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Product

634.70M

79.60%

Product And Service Other

162.70M

20.40%

Service and other revenue

162.70M

20.40%

地区USD

名称

营收

占比

United States

222.90M

27.95%

Rest of Europe

213.40M

26.76%

Rest of Asia Pacific

127.40M

15.98%

China

114.70M

14.38%

Other

59.90M

7.51%

Germany

59.10M

7.41%

业务

地区

业务USD

名称

营收

占比

Product

634.70M

79.60%

Product And Service Other

162.70M

20.40%

Service and other revenue

162.70M

20.40%

股东统计

更新时间: 11月17日周一

持股股东

股东类型

持股股东

占比

Laukien (Frank H)

26.60%

Orbis Investment Management Ltd.

9.31%

Fidelity Management & Research Company LLC

7.52%

The Vanguard Group, Inc.

6.83%

Pallas Capital Advisors LLC

6.24%

其他

43.50%

持股股东

占比

Laukien (Frank H)

26.60%

Orbis Investment Management Ltd.

9.31%

Fidelity Management & Research Company LLC

7.52%

The Vanguard Group, Inc.

6.83%

Pallas Capital Advisors LLC

6.24%

其他

43.50%

股东类型

持股股东

占比

Investment Advisor

50.95%

Individual Investor

31.97%

Investment Advisor/Hedge Fund

25.95%

Hedge Fund

8.24%

Research Firm

2.61%

Pension Fund

1.17%

Sovereign Wealth Fund

0.76%

Bank and Trust

0.38%

Insurance Company

0.21%

机构持股



更新时间: 12月8日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q4

887

137.27M

94.12%

+111.45K

2025Q3

908

137.16M

94.45%

+8.73M

2025Q2

904

127.18M

89.58%

+1.13M

2025Q1

886

125.13M

85.85%

-5.11M

2024Q4

855

125.47M

82.99%

+4.02M

2024Q3

812

120.93M

80.76%

+2.25M

2024Q2

782

118.65M

76.64%

+5.15M

2024Q1

766

113.09M

82.81%

-916.64K

2023Q4

748

112.27M

83.16%

-472.55K

2023Q3

723

112.40M

83.64%

-8.12M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Laukien (Frank H)

40.41M

26.64%

+31.93K

+0.08%

Aug 15, 2025

Orbis Investment Management Ltd.

4.68M

3.08%

+4.68M

Jun 30, 2025

Fidelity Management & Research Company LLC

7.47M

4.92%

-2.35M

-23.89%

Jun 30, 2025

The Vanguard Group, Inc.

10.40M

6.86%

-122.86K

-1.17%

Jun 30, 2025

Pallas Capital Advisors LLC

9.50M

6.26%

+5.56K

+0.06%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

9.40M

6.2%

-803.98K

-7.88%

Jun 30, 2025

Laukien (Joerg C)

7.52M

4.95%

Apr 01, 2025

T. Rowe Price Investment Management, Inc.

11.43M

7.53%

-952.71K

-7.69%

Jun 30, 2025

State Street Investment Management (US)

3.78M

2.49%

-42.78K

-1.12%

Jun 30, 2025

Edmond de Rothschild Asset Management (France) S.A.

1.51M

0.99%

+1.51M

Jun 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

First Trust NYSE Arca Biotechnology Index Fund

3.71%

ProShares Nanotechnology ETF

3.34%

State Street SPDR S&P Kensho Future Security ETF

1.27%

Ballast Small/Mid Cap ETF

1.13%

AB Disruptors ETF

0.63%

Invesco NASDAQ Future Gen 200 ETF

0.61%

State Street SPDR S&P Kensho New Econ Comp ETF

0.57%

iShares Health Innovation Active ETF

0.4%

iShares Biotechnology ETF

0.36%

JPMorgan Active Small Cap Value ETF

0.31%

First Trust NYSE Arca Biotechnology Index Fund

占比3.71%

ProShares Nanotechnology ETF

占比3.34%

State Street SPDR S&P Kensho Future Security ETF

占比1.27%

Ballast Small/Mid Cap ETF

占比1.13%

AB Disruptors ETF

占比0.63%

Invesco NASDAQ Future Gen 200 ETF

占比0.61%

State Street SPDR S&P Kensho New Econ Comp ETF

占比0.57%

iShares Health Innovation Active ETF

占比0.4%

iShares Biotechnology ETF

占比0.36%

JPMorgan Active Small Cap Value ETF

占比0.31%

分红派息



近5年累计派现 138.20M 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

Nov 04, 2025

BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Jan 02, 2026 going ex on Dec 08, 2025

Dec 08, 2025

Jan 02, 2026

Dec 08, 2025

Aug 12, 2025

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Oct 03, 2025 going ex on Sep 23, 2025

Sep 23, 2025

Oct 03, 2025

Sep 23, 2025

May 15, 2025

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 27, 2025 going ex on Jun 16, 2025

Jun 16, 2025

Jun 27, 2025

Jun 16, 2025

Feb 21, 2025

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 28, 2025 going ex on Mar 17, 2025

Mar 17, 2025

Mar 28, 2025

Mar 17, 2025

Nov 18, 2024

BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 16, 2024 going ex on Dec 02, 2024

Dec 02, 2024

Dec 16, 2024

Dec 02, 2024

Aug 14, 2024

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 16, 2024 going ex on Aug 30, 2024

Sep 02, 2024

Sep 16, 2024

Aug 30, 2024

May 15, 2024

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Jun 17, 2024 going ex on Jun 03, 2024

Jun 03, 2024

Jun 17, 2024

Jun 03, 2024

Feb 16, 2024

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Mar 15, 2024 going ex on Feb 29, 2024

Mar 01, 2024

Mar 15, 2024

Feb 29, 2024

Nov 20, 2023

BRKR.NB Final Cash Dividend of gross USD 0.05 paid on Dec 15, 2023 going ex on Nov 30, 2023

Dec 01, 2023

Dec 15, 2023

Nov 30, 2023

Aug 14, 2023

BRKR.NB Interim Cash Dividend of gross USD 0.05 paid on Sep 15, 2023 going ex on Aug 31, 2023

Sep 01, 2023

Sep 15, 2023

Aug 31, 2023

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

Bruker Corp的前五大股东是谁？



Bruker Corp 的前五大股东如下：
Laukien (Frank H)持有股份：40.41M，占总股份比例：26.64%。
Orbis Investment Management Ltd.持有股份：4.68M，占总股份比例：3.08%。
Fidelity Management & Research Company LLC持有股份：7.47M，占总股份比例：4.92%。
The Vanguard Group, Inc.持有股份：10.40M，占总股份比例：6.86%。
Pallas Capital Advisors LLC持有股份：9.50M，占总股份比例：6.26%。